The CRC Blueprint

My scientific approach to my own cancer – shared with you.

Recruiting now

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Phase 1 · 383 people · 53 sites in 8 countries · Recruiting now

August 11, 2026
Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases

Phase 2 · randomised · 62 people · 1 site in China · Recruiting now

August 11, 2026
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Phase 2 · randomised · 499 people · 4 sites in United States · Recruiting now

August 11, 2026
Safety and Effectiveness Evaluation of the COLO-BT as an Alternative Treatment to the Ileostomy

Not phased · randomised · 256 people · 3 sites in United States · Recruiting now

August 11, 2026
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

Phase 1 · 914 people · 48 sites in 10 countries · Recruiting now

August 11, 2026
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2

Phase 2 · 111 people · 54 sites in 11 countries · Recruiting now

August 11, 2026
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Phase 2 · 50 people · 1 site in United States · Recruiting now

August 11, 2026
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Phase 1 · 300 people · 38 sites in 5 countries · Recruiting now

August 11, 2026
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Phase 2 · 500 people · 165 sites in 19 countries · Recruiting now

August 11, 2026
Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers

Phase 2 · 34 people · 1 site in China · Recruiting now

August 11, 2026